Patients with non-cardiac chest pain (NCCP) recelving an empirical trial of high dose lansoprazole, demonstrate early symptom response. A double blind, placebo-controlled trial

2001 ◽  
Vol 120 (5) ◽  
pp. A221 ◽  
Author(s):  
Ronnie Fass ◽  
Gloria Pulliam ◽  
Craig W. Hayden
Sign in / Sign up

Export Citation Format

Share Document